AD/PD 2026
Booth 15A
AD/PD 2026
Booth 15A
-
Date
March 17th - 21st, 2026
Introducing our brands
Featured Products
Agenda
Stay tuned for more talks and posters.
Wednesday, March 18
| Time | Type | Description | Room / Location | Presenter |
| 10:45 AM | Neuro Nook | Chemiluminescence ELISA, New product launch (Faster, Shorter ELISA)
Abcam | Booth #15A | Petr Hejak |
| 1:45 PM | Neuro Nook | Better classification in borderline cases using NfL with p‑Tau217/Aβ42
BecDX. | Booth #15A | Corey Carlson |
| 4:30 PM | Product Theater | BD p‑Tau217: A New Direction for great specificity for AD Pathology
BecDX. | Product Theater | Nick Ashton |
Thursday, March 19
| Time | Type | Description | Room / Location | Presenter |
| 10:45 AM | Neuro Nook | Chemically peptide-ligated protein standards enable antibody validation and quantification of phosphorylated Tau in Alzheimer’s disease samples.
Abcam | Booth #15A | Petr Hejak |
| 1:45 PM | Neuro Nook | Better classification in borderline cases using NfL with p‑Tau217/Aβ42
BecDX. | Booth #15A | Corey Carlson |
Friday, March 20
| Time | Type | Description | Room / Location | Presenter |
| 10:45 AM | Neuro Nook | Chimeric Antibodies: One Clone, Many Species
BecDX. | Booth #15A | Tom Bright |
| 1:45 PM | Neuro Nook | Chemiluminescence ELISA, New product launch (Faster, Shorter ELISA)
BecDX. | Booth #15A | Petr Hejak |
Saturday, March 21
| Time | Type | Description | Room / Location | Presenter |
| 11:24 AM - 11.40 AM | Oral Presentation | Neuroimaging correlates and diagnostic performance of a fully automated plasma p-Tau217/Aβ42 ratio assay in a clinical cohort with Alzheimer’s disease
BecDX. | Aud 15 | Yoo Hyun Um |
Posters
Tuesday, March 17 - Thursday, March 19
| Time | Type | Description | Room / Location | Presenter |
| N/A | Poster | Chemically peptide-ligated protein standards enable antibody validation and quantification of phosphorylated Tau in Alzheimer’s disease samples.
Abcam | TBC | Petr Hejak |
| N/A | Poster | Chimeric antibodies in Alzheimer’s disease research: Properties and applications in low-multiplexing assays
Abcam | TBC | Tom Bright |
| N/A | Poster | Spatial Proteomic Mapping in Alzheimer’s Disease Using Multiplex Immunostaining and AI-Powered Image Analysis
Abcam | TBC | Aniko Karpati |
| N/A | Poster | Reliable Antibodies for Neuroscience: APOE4 as a Case Study of Abcam’s Enhanced Validation Framework
Abcam | TBC | Aniko Karpati |
| N/A | Poster | Analytical and Clinical Evaluation of Alzheimer's Disease Plasma Biomarkers on the Random-Access DxI 9000 Analyzer
BecDX. | TBC | Daniel Antwi-Berko |
| N/A | Poster | Brain-derived p-tau217 in plasma shows enhanced response to alzheimer's pathology
BecDX. | TBC | Wagner S. Brum |
| N/A | Poster | High-throughput, fully automated immunoassay for plasma brain-derived p-tau217
BecDX. | TBC | Corey Carlson |